Clinical Report: Positive Impact of Complementary Traditional Chinese Medicine
Overview
Adjunctive Chinese herbal medicine (CHM) use in breast cancer patients receiving Western medicine was associated with significant improvements in constitution-related symptoms and quality of life (QOL). This study highlights the potential supportive role of TCM in managing treatment-related symptoms.
Background
Breast cancer remains a leading cause of cancer-related mortality, with treatments often resulting in substantial symptom burden and impaired quality of life. Integrative oncology practices increasingly incorporate traditional Chinese medicine (TCM) to mitigate these adverse effects. Understanding the impact of TCM on symptom management and QOL is crucial for enhancing patient care.
Data Highlights
Symptom
Odds Ratio (OR)
95% Confidence Interval (CI)
Fatigue
1.92
1.18–3.12
Dry Eyes
2.15
1.27–3.65
Hot Flushes
1.87
1.10–3.19
Physical Pain Interference
2.08
1.24–3.50
Perception of Physical Environment
1.69
1.03–2.76
Key Findings
Adjunctive CHM use was associated with improved fatigue, dry eyes, and hot flushes in breast cancer patients.
Patients using CHM reported reduced interference from physical pain and improved perception of their physical environment.
These findings align with TCM descriptions of qi–yin deficiency and stasis-stagnation.
Real-world evidence supports the integration of TCM into breast cancer care to enhance symptom management.
Further research is needed to establish causal relationships between CHM and symptom improvement.
Clinical Implications
Healthcare providers should consider the incorporation of adjunctive traditional Chinese medicine as a supportive care option for breast cancer patients experiencing treatment-related symptoms. This approach may enhance patient quality of life and symptom management, although careful monitoring for potential herb-drug interactions is essential.
Conclusion
The study suggests that adjunctive CHM may play a beneficial role in managing symptoms and improving quality of life for breast cancer patients. Further investigation is warranted to confirm these findings and optimize integrative treatment strategies.
